BNTX

BioNTech SE (BNTX)

Last Price$122.90.6%
Market Cap$29.5B
LTM Return on Invested Capital (ROIC)
(41.4%)
5Y avg
21.3%
Biotechnology industry median
(123.1%)
Stock quality & Intrinsic value
6/10
0.3% undervalued

BioNTech SE Return on Invested Capital (ROIC)

Annual
Quarterly
LTM
Industry median
Company stand-alone
BNTX
Healthcare
Crunching data... Almost there!
Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Return on Invested Capital (ROIC)
0.0%
(56.9%)
(33.2%)
(87.2%)
23.1%
151.5%
83.4%
6.8%
BNTX
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BNTX and see if it's the right time to invest.
Dive in

BioNTech SE (BNTX) Return on Invested Capital (ROIC) comparison analysis

Crunching data... Almost there!

BNTX key stats

USD
EUR
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is BioNTech SE's Return on Invested Capital (ROIC)?

As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is (41.4%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for BioNTech SE have been 56.0% over the past three years, and 22.3% over the past five years.

2) Is BioNTech SE's Return on Invested Capital (ROIC) Good?

As of today, BioNTech SE's Return on Invested Capital (ROIC) is (41.4%), which is higher than industry median of (123.1%). It indicates that BioNTech SE's Return on Invested Capital (ROIC) is Good.

3) How does BioNTech SE's Return on Invested Capital (ROIC) compare to its peers?

As of today, BioNTech SE's Return on Invested Capital (ROIC) is (41.4%), which is lower than peer median of (16.7%). The list of peers includes UTHR, NVO, REGN, GMAB, VRTX, INCY, ALNY, BGNE, ARGX, MRNA.